However, by contrast, other studies have demonstrated that COX-2 expression is absent in normal colonic mucosa but high in tumor tissue, and that the long-term use of non-steroidal anti-inflammatory drugs lowers the risk of developing CRC by 40–50% (12). The gene discussed is PTGS2; the disease is colorectal carcinoma.